80 likes | 88 Views
As per the drug class, the NOACs segment is expected to show the fastest market growth and grow at a CAGR of 8.0% from 2018 to 2025. On the basis of the route of administration, the oral anticoagulant segment held more than half of the global market share in 2017 and is expected to remain dominant throughout the forecast period. By application, the deep vein thrombosis (DVT) segment is expected to exhibit the fastest growth at a CAGR of 8.4% from 2018 to 2025. Region-wise, the Asia-Pacific region is expected to experience growth at the highest rate, registering a CAGR of 9.2% during the forecast period.<br>
E N D
Anticoagulants Market Expected to Reach $43,427 Million by 2025 Opportunity Analysis and Industry Forecast, 2016-2023 Global Opportunity Analysis and Industry Forecast, 2018-2025
Anticoagulants Market “Increase in prevalence of DVT, PE, and cardiac disease across the world plays a major role in the growth of the anticoagulant drugs market. Furthermore, increase in adoption of NOACs is expected to boost the demand for anticoagulants in the coming years.”
Anticoagulants Market Overview According to a new report published by Allied Market Research, titled, Anticoagulants Market, by Drug Class, Route of Administration, Application: Global Opportunity Analysis and Industry Forecast, 2018-2025," the market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025. Access Full Summary : https://www.alliedmarketresearch.com/request-sample/1673 Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood.
Anticoagulants Market Segmentation • The global anticoagulants market is segmented based on drug class, route of administration, application, and region. • Region-wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). • On the basis of drug class, the anticoagulants market is classified as NOACs, heparin and LMWH, vitamin K antagonist, and others.
Key Players of Anticoagulants Market • • • • • • • • • • Aspen Holdings Bayer AG Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Daiichi Sankyo Company Limited GlaxoSmithKline plc. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Pfizer, Inc. Portola Pharmaceuticals, Inc. Sanofi S.A.
Key Benefits of Anticoagulants Market • The study provides an in-depth analysis of the anticoagulants market size along with the current trends and future estimations to elucidate the imminent investment pockets. It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the predominant anticoagulants market opportunities. A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities. The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global anticoagulants market. • • •
Anticoagulants Market North America Europe Asia-Pacific LAMEA
Anticoagulants Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request- sample/1673 Follow Us On